Cholecystokinin Octapeptide Ammonium: Mechanisms of ANP Secretion via NOX4–PGC-1α–PPARα/PPARγ Signaling

Study Background and Research Question

Atrial natriuretic peptide (ANP) is a cardiac hormone central to the regulation of fluid volume, blood pressure, and the cardiovascular response to oxidative stress. While the role of cholecystokinin (CCK) as a gut-brain peptide is well established, its function within cardiomyocytes and its interaction with cardiac hormones such as ANP has remained incompletely defined. Previous studies have identified CCK and its receptors (CCK1R and CCK2R) in cardiac tissue, implicating them in hemodynamic regulation and myocardial remodeling. However, the direct molecular mechanisms by which CCK, particularly its active octapeptide form (CCK-8 ammonium), regulates ANP secretion were not previously elucidated. The primary research question addressed by Han et al. was whether CCK-8 ammonium can drive ANP secretion in the heart, and if so, through which intracellular signaling pathways (Han et al., 2022).

Key Innovation from the Reference Study

The core innovation of the referenced work lies in the identification of a specific signaling axis—NOX4–PGC-1α–PPARα/PPARγ—through which sulfated CCK-8 promotes ANP secretion in isolated rat atria. Critically, the study distinguishes the effects of sulfated versus desulfated CCK-8, demonstrating that only the sulfated form (CCK-8 ammonium) is capable of activating this pathway. This finding clarifies a direct receptor-mediated mechanism linking a neuropeptide to a canonical cardiac hormone, and underscores the importance of post-translational modifications (sulfation) for biological activity. The authors also reveal that CCK-8 modulates atrial contractility via potassium channel activation, further expanding the functional scope of CCK-8 in cardiac physiology (Han et al., 2022).

Methods and Experimental Design Insights

The study utilized isolated, perfused beating rat atria to provide a controlled ex vivo system for investigating the acute effects of CCK-8 ammonium. ANP secretion was quantified by radioimmunoassay, while reactive oxygen species (ROS) production (H₂O₂) and arachidonic acid (AA) release were measured using ELISA-based assays. Protein and mRNA expression levels of key signaling molecules—NOX4, PGC-1α, PPARα, and PPARγ—were assessed by Western blotting and RT-qPCR. The investigators further dissected receptor specificity by comparing sulfated and desulfated CCK-8, and by employing pharmacological inhibitors targeting CCK receptors, ANP receptor, and potassium channels. This approach allowed for the delineation of both upstream receptor events and downstream intracellular signaling (Han et al., 2022).

Core Findings and Why They Matter

1. Sulfated CCK-8 (CCK-8 ammonium) specifically upregulates ANP secretion: The study found that only the sulfated form of CCK-8 increased ANP secretion, establishing the crucial role of sulfation for biological activity. This aligns with prior knowledge that desulfated CCK-8 lacks functional efficacy (Han et al., 2022).

2. Activation of the NOX4–PGC-1α–PPARα/PPARγ axis: CCK-8 ammonium binding to CCK receptors triggered phosphorylation of cytosolic phospholipase A2, promoting arachidonic acid release and upregulating NOX4 expression. Increased NOX4 activity elevated H₂O₂ production, which in turn promoted PGC-1α expression via p38 MAPK and Akt signaling. This cascade culminated in the activation of PPARα and PPARγ, transcriptional regulators essential for ANP secretion.

3. Modulation of atrial dynamics: CCK-8 ammonium also exerted a negative inotropic effect on atrial contractility through activation of K_ATP and BK_Ca channels. The involvement of potassium channels suggests a link between neuropeptide signaling and cardiac electrophysiology.

4. Feedback mechanisms involving ANP: The presence of an ANP receptor inhibitor enhanced CCK-8-induced NOX4 and catalase expression, while reversing CCK-8-driven SOD upregulation. This indicates a negative feedback loop wherein ANP secretion modulates ROS production and antioxidant enzyme expression, contributing to cardiac oxidative balance.

These findings clarify how CCK-8 ammonium, as a G protein-coupled receptor ligand, orchestrates a coordinated response involving both hormone secretion and redox homeostasis. The relevance extends to cardiovascular pathophysiology, as dysregulation of ANP and ROS is implicated in heart failure and hypertrophy (Han et al., 2022).

Comparison with Existing Internal Articles

The present study’s mechanistic analysis is consistent with the internal summary "CCK-8 Ammonium Drives ANP Secretion via NOX4–PGC-1α–PPAR Signaling", which also highlights the direct link between CCK-8 ammonium stimulation and activation of the NOX4–PGC-1α–PPARα/PPARγ pathway in isolated rat atria. Additionally, the internal article "Cholecystokinin Octapeptide Ammonium: Decoding Neurobehav..." expands on the pleiotropic roles of CCK-8 ammonium in neuronal apoptosis inhibition and modulation of immune responses, supporting the notion of CCK-8 as a versatile signaling molecule across organ systems. However, the reference study uniquely provides detailed experimental evidence in cardiac tissue, bridging molecular signaling with functional hormone release.

Limitations and Transferability

The use of ex vivo isolated rat atria provides a high degree of experimental control but may not fully recapitulate in vivo systemic physiology, where additional neurohumoral and hemodynamic factors are present. The findings are robust for acute responses and mechanistic dissection, yet the transferability to chronic models of cardiovascular disease or to other species remains to be validated. Furthermore, while the study clarifies the pathway for promotion of atrial natriuretic peptide secretion, broader physiological effects (such as blood pressure regulation or long-term cardiac remodeling) were not addressed. The concentration range for effective CCK-8 ammonium stimulation (0.01–1 μmol/L in vitro) is well-aligned with previous reports (product information), but extrapolation to human systems should be approached cautiously.

Protocol Parameters

• CCK-8 ammonium (sulfated form) concentration: 0.01–1 μmol/L for in vitro experiments in isolated rat atria; 1–10 pmol/g body weight for in vivo protocols (product info).
• Receptor specificity: CCK1R and CCK2R agonism is required for ANP secretion and downstream signaling; use specific antagonists for pathway dissection.
• Storage and handling: Store CCK-8 ammonium at –20°C, sealed, dry, protected from light, under nitrogen. Prepare solutions fresh; do not store long-term (product info).
• Solubility: Compound is insoluble in DMSO, ethanol, and water; refer to manufacturer recommendations for reconstitution.

Research Support Resources

Researchers investigating the regulation of cardiac hormone secretion, inhibition of apoptosis in neuronal cells, or modulation of immune responses can utilize Cholecystokinin octapeptide ammonium (SKU C8717) as a validated reagent for activating CCK1R/CCK2R pathways. The experimental parameters and storage conditions provided in the reference and product dossier support reproducible application in cardiovascular and neuropharmacology workflows.